Last reviewed · How we verify
Total Dose Infusion of Ferumoxytol (1020mg) in 15 Minutes for Iron Defeciency Anemia
The aim of the study is to recruit 30 patients who have been referred to Auerach Hematology Oncology Assoc. for the treatment of iron defeciency anemia with iv iron (Ferumoxytol 1020 mg) administered via infusion pump over 15 minutes. To ascertain acute safety and tolerability of ferumoxytol during immediate post dosing observation period. Assess additional safety profile and laboratory assessment at follow up visit and interim telephone follow up.
Details
| Lead sponsor | Auerbach Hematology Oncology Associates P C |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 60 |
| Start date | 2011-06 |
| Completion | 2012-03 |
Conditions
- Iron Deficiency Anemia
Interventions
- ferumoxytol
Primary outcomes
- Efficacy of 1020 mg of Ferumoxytol Over 15 Minutes. Hemoglobin Measurements Will Take Place at Four and Eight Week Visit. — baseline 4 weeks and 8 weeks
Percentage of participates with indicated increase in hemoglobin from baseline to week 4 and week 8
Countries
United States